LEE Kenneth B JR
SEC-identified person · CIK 1208570 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Biocryst Pharmaceuticals INC BCRX | Director | filed 2011–2023 |
| Hyperion Defi, INC. HYPD | Director | filed 2018–2022 |
| Phasebio Pharmaceuticals Inc PHAS | Officer | filed 2018–2018 |
| G1 Therapeutics, Inc. GTHX | Officer | filed 2017–2018 |
| Aralez Pharmaceuticals Inc. ARLZ | Director | filed 2016–2017 |
| Clearside Biomedical, Inc. CLSD | Officer | filed 2016–2017 |
| Pozen INC /NC POZN | Director | filed 2006–2015 |
| Maxygen INC MAXY | Director | filed 2009–2012 |
| Inspire Pharmaceuticals INC ISPH | Director | filed 2006–2011 |
| OSI Pharmaceuticals INC OSIP | Director | filed 2007–2010 |
| CV Therapeutics INC CVTX | Director | filed 2006–2009 |
| Abgenix INC ABGX | Director | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.